Revelation Biosciences Warrant
REVBW
11 hedge funds and large institutions have $23.6K invested in Revelation Biosciences Warrant in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
7.71% more ownership
Funds ownership: 0% → 7.71% (+7.7%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
8% less funds holding
Funds holding: 12 → 11 (-1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
81% less capital invested
Capital invested by funds: $123K → $23.6K (-$99.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
+$482 |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$214 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCAM
Owl Creek Asset Management
New York
|
-$21.8K |
| 2 |
Jane Street
New York
|
-$99 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LA
1
Linden Advisors
New York
| $9.25K | – | – | – |
|
|
OCAM
2
Owl Creek Asset Management
New York
| $3.93K | -$21.8K | -685,565 | -70% |
|
|
YCM
3
Yakira Capital Management
Westport,
Connecticut
| $3.23K | – | – | – |
|
|
TI
4
Telemetry Investments
New York
| $2K | – | – | – |
|
|
PAMP
5
Polar Asset Management Partners
Toronto,
Ontario, Canada
| $1.35K | – | – | – |
|
|
6
Jane Street
New York
| $1.08K | -$99 | -3,103 | -4% |
|
|
AC
7
Ayrton Capital
Westport,
Connecticut
| $983 | – | – | – |
|
|
WAM
8
Wolverine Asset Management
Chicago,
Illinois
| $969 | +$214 | +6,734 | +10% |
|
|
PFM
9
Privium Fund Management
Amsterdam,
Netherlands
| $497 | – | – | – |
|
|
EPM
10
Equitec Proprietary Markets
Chicago,
Illinois
| $262 | – | – | – |
|
|
FTUS
11
Flow Traders U.S.
New York
| – | +$482 | +15,159 | New |
|
REVBW Hedge Fund Activity: Q4 2022 in Review
11 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q4 2022, worth a combined $23.6K — down 81% from $123K a quarter earlier.
Fund positioning in REVBW was balanced in Q4 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Flow Traders U.S., opening a new position worth an estimated $482. The largest seller was Owl Creek Asset Management, cutting an estimated $21.8K.
- 11 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q4 2022, down from 12 in Q3 2022.
- Funds reported $23.6K of Revelation Biosciences Warrant stock for Q4 2022, down 81% quarter-over-quarter.
- 1 fund opened new Revelation Biosciences Warrant positions in Q4 2022 and 1 closed out, a net change of 0 holders.
- The largest Revelation Biosciences Warrant buyer in Q4 2022 was Flow Traders U.S., an estimated $482 added.
- The largest Revelation Biosciences Warrant seller in Q4 2022 was Owl Creek Asset Management, an estimated $21.8K sold.
Based on aggregated 13F filings for Q4 2022.